Dianthus Therapeutics to Participate in Five Investor Conferences During November
Key Highlights
- ➤Dianthus Therapeutics (DNTH) announces participation in five November investor conferences
- ➤Marino Garcia scheduled for four conference fireside chats during November
- ➤Ryan Savitz scheduled to host one-on-one investor meetings at three conferences
NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company’s participation in five investor conferences. * Guggenheim 3rd Annual Healthcare Innovation Conference: Marino Garcia, CEO, will participate in a fireside chat on Monday, November 9, 2026, at 11:00 a.m. ET. Marino Garcia and Ryan Savitz, EVP, CFO & CBO, will also host one-on-one investor meetings.
* Stifel 2026 Healthcare Conference: Marino Garcia will participate in a fireside chat on Wednesday, November 11, 2026, at 9:20 a.m. ET. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings.
Get started
Create a free account to read the full story.